病例报告 : 利妥昔单抗加苯达莫司汀后 , 高剂量静脉免疫球蛋白作为晚期免疫性粒细胞缺乏症的成功治疗。
关键词: Waldenström’s macroglobulinemia agranulocytosis bendamustine immunoglobulin rituximab
Mesh : Aged Agranulocytosis / chemically induced drug therapy immunology Antineoplastic Combined Chemotherapy Protocols / adverse effects therapeutic use Bendamustine Hydrochloride / administration & dosage adverse effects Dose-Response Relationship, Drug Humans Immunoglobulins, Intravenous / administration & dosage therapeutic use Male Rituximab / administration & dosage adverse effects Treatment Outcome Waldenstrom Macroglobulinemia / drug therapy
来 源:
DOI:10.3389/fimmu.2021.798251
PDF(Pubmed)